Collins Charles J. 4
4 · LUMINEX CORP · Filed Jul 20, 2020
Insider Transaction Report
Form 4
LUMINEX CORPLMNX
Collins Charles J.
SR VP, R&D - US
Transactions
- Sale
Common Stock
2020-07-17$37.00/sh−13,343$493,691→ 34,554 total - Exercise/Conversion
Stock Option (Right To Buy)
2020-07-17$19.48/sh−9,405$183,209→ 0 totalExercise: $19.48From: 2017-03-11Exp: 2023-03-10→ Common Stock (9,405 underlying) - Exercise/Conversion
Stock Option (Right To Buy)
2020-07-17$18.04/sh−13,343$240,708→ 33,542 totalExercise: $18.04From: 2018-03-10Exp: 2024-03-10→ Common Stock (13,343 underlying) - Exercise/Conversion
Common Stock
2020-07-17$19.48/sh+9,405$183,209→ 43,959 total - Exercise/Conversion
Common Stock
2020-07-17$18.04/sh+13,343$240,708→ 47,897 total - Sale
Common Stock
2020-07-17$37.00/sh−9,405$347,985→ 34,554 total
Footnotes (1)
- [F1]This sale is being made pursuant to a trading plan intended to comply with Rule 10b5-1 adopted by the seller on May 28, 2020. The representation regarding the seller's knowledge of material adverse non-public information speaks as of the date that the aforementioned trading plan was adopted.